Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 286-291

  Filho, Carlos B ^a   Fabbro, Lucian Del ^a   De Gomes, Marcelo G ^a   Goes, André T R ^a   Souza, Leandro C ^a   Boeira, Silvana P ^a   Jesse, Cristiano R ^a  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

opioid receptor; Antidepressant; Forced swimming test; Hesperidin; Opioid receptor

Indexed keywords

17 METHYLNALOXONE; 2 (3,4 DICHLOROPHENYL) N METHYL N [1 (3 ISOTHIOCYANATOPHENYL) 2 (1 PYRROLIDINYL)ETHYL]ACETAMIDE; ADENOSINE RECEPTOR; CAFFEINE; CLOCINNAMOX; DELTA OPIATE RECEPTOR; HESPERIDIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; HESPERIDIN; MALE; MICE; NALOXONE; NALTREXONE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, PURINERGIC P1; SWIMMING;

EID: 84871923601     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.003     Document Type: Article

References (47)

1. S.T. Ahmad, W. Arjumand, S. Nafees, A. Seth, N. Ali, S. Rashid, and S. Sultana Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apopotosis and inflammation Toxicol. Lett. 205 2012 149 161
2. J.V. Aldrich, and J.P. McLaughlin Peptide κ-opioid receptor ligands: potential fordrug development AAPS J. 11 2009 312 322
3. E. Berrocoso, M.O. Rojas-Corrales, and J.A. Micó Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice Neurosci. Lett. 363 2004 25 28 (Pubitemid 38639845)
4. E. Berrocoso, and J.A. Mico Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice modelo f depression Int. J. Neuropsychopharmacol. 128 2009 1033 1044
5. E. Berrocoso, P. Sanchez-Blasquez, J. Garzon, and J.A. Mico Opiates as antidepressants Curr. Pharm. Des. 15 2009 1612 1622
6. F. Borsini, and A. Meli Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94 1988 147 160 (Pubitemid 18040687)
7. P.S. Brocardo, J. Budni, K.R. Lobato, A.R. Santos, and A.L. Rodrigues Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test Behav. Brain Res. 200 2009 122 127
8. G.V. Carr, D.A. Bangasser, T. Bethea, M. Young, R.J. Valentino, and I. Lucki Antidepressant-like effects of kappa-opioid receptors antagonists in Wistar Kyoto rats Neuropsychopharmacology 35 2010 752 763
9. E. Chartoff, A. Sawyer, A. Rachlin, D. Potter, A. Pliakas, and W.A. Carlezon Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats Neuropharmacology 62 2012 167 176
10. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.F. Wang, and L.T. Young Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol. Psychiatry 50 2001 260 265 (Pubitemid 32778442)
11. J. Cho Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin Arch. Pharm. Res. 29 2006 699 706 (Pubitemid 44338469)
12. R.A. Cunha Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors Neurochem. Int. 38 2001 107 125 (Pubitemid 32014381)
13. S.P. Fernández, C. Wasowski, A.C. Paladini, and M. Marder Synergistic interaction between hesperidin, a natural flavonoid, and diazepam Eur. J. Pharmacol. 512 2005 189 198 (Pubitemid 40544353)
14. A. Garg, S. Garg, L.J. Zaneveld, and A.K. Singla Chemistry and pharmacology of the Citrus bioflavonoid hesperidin Phytother. Res. 15 2001 655 669 (Pubitemid 34016792)
15. S. Grimwood, Y. Lu, A.W. Schmidt, M.A. Vanase-Frawley, A. Sawant-Basak, E. Miller, S. McLean, J. Freeman, S. Wong, J.P. McLaughlin, and P.R. Verhoest Pharmacological characterization of 2-methyl-N-((2'-pyrrolidin-1-ylsulfonyl) biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptor J. Pharmacol. Exp. Ther. 339 2011 555 566
16. H.B. Gutstein, and H. Akil Opioid analgesics, in Goodman & Gilman's: The Pharmacological Basis of Therapeutics 11th ed., 2006 McGraw-Hill Publishers New York pp. 547-590
17. 2-induced cytotoxicity in PC12 cells J. Agric. Food Chem. 56 2008 859 864
18. 2A receptors Neurosci. Lett. 355 2004 21 24 (Pubitemid 38077175)
19. 1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test Brain Res. Bull. 67 2005 53 61 (Pubitemid 41225318)
20. M.P. Kaster, J. Budni, A.R. Santos, and A.L. Rodrigues Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test Eur. J. Pharmacol. 576 2007 91 98 (Pubitemid 47588261)
21. M.L. Laorden, M.T. Castells, and M.V. Milanés Effects of U-50488H and U-50488H withdrawal on c-fos expression in the rat paraventricular nucleus. Correlation with c-fos in brainstem catecholaminergic neurons Br. J. Pharmacol. 138 2003 1544 1552 (Pubitemid 36609650)
22. P.Y. Law, Y.H. Wong, and H.H. Loh Molecular mechanisms and regulation of opioid receptor signaling Annu. Rev. Pharmacol. Toxicol. 40 2000 389 430 (Pubitemid 30340688)
23. K.H. Lee, M.H. Yeh, S.T. Kao, C.M. Hung, and C.C. Yeh The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kB in human hepatocellular carcinoma cells Toxicol. Lett. 194 2010 42 49
24. 2A receptors in the antidepressant-like effect of zinc in the forced swimming test Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 994 999 (Pubitemid 351609235)
25. L.M. Loscalzo, C. Wasowski, A.C. Paladini, and M. Marder Opoid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines Eur. J. Pharmacol. 580 2008 306 313
26. L.M. Loscalzo, T.T. Yow, C. Wasowski, M. Chebib, and M. Marder Hesperidin induces antinociceptive effect in mice and its aglycone, hesperetin, binds to μ-opioid receptor and inhibits GIRK1/2 currents Pharmacol. Biochem. Behav. 99 2011 333 341
27. M. Maes, N. De Vos, R. Pioli, P. Demedts, A. Wauters, H. Neels, and A. Christophe Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness J. Affect. Disord. 58 2000 241 246 (Pubitemid 30232781)
28. S.D. Mague, A.M. Pliakas, M.S. Todtenkopf, H.C. Tomasiewicz, Y. Zhang, W.C. Stevens Jr, R.M. Jones, P.S. Portoghese, and W.A. Carlezon Jr. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats J. Pharmacol. Exp. Ther. 305 2003 323 330 (Pubitemid 36373867)
29. M. Makino, Y. Kitano, C. Komiyama, M. Hirohashi, and K. Takasuna Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test Br. J. Pharmacol. 30 2000 1269 1274 (Pubitemid 30488589)
30. J.P. McLaughlin, M. Marton-Popovici, and C. Chavkin Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses J. Neurosci. 23 2003 5674 5683 (Pubitemid 36807845)
31. A. Mendonça, A.M. Sebastião, and J.A. Ribeiro Adenosine: does it have a neuroprotective role after all? Brain Res. Rev. 33 2000 258 274
32. M. Nibuya, S. Morinobu, and R.S. Duman Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J. Neurosci. 15 1995 7539 7547
33. D.J. Nutt Relationship of neurotransmitters to the symptoms of major depressive disorder J. Clin. Psychiatry 69 Suppl E1 2008 4 7
34. M.C. Olianas, S. Dedoni, and P. Onali Kappa-opioid receptor agonist activity of the atypical antidepressant mianserin Br. J. Pharmacol. 167 2012 1329 1341
35. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732 (Pubitemid 8073804)
36. S. Rahman Targenting opioid receptors: a new treatment for brain disorders CNS Neurol. Disord. Drug Targets 9 2010 128
37. J.A. Ribeiro, A.M. Sebastião, and A. Mendonça Adenosine receptors in the nervous system: pathophysiological implications Prog. Neurobiol. 68 2003 377 392
38. A.L.S. Rodrigues, G.L. Da Silva, A.S. Mateussi, E.S. Fernandes, O.G. Miguel, R.A. Yunes, J.B. Calixto, and A.R. Santos Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus Life Sci. 70 2002 1347 1358 (Pubitemid 34159092)
39. N.C. Ross, K.J. Reilley, T.F. Murray, J.V. Aldrich, and J.P. McLaughlin Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism Br. J. Pharmacol. 165 2012 1097 1108
40. A.A. Russo-Neustadt, H. Alejandre, C. Garcia, A.S. Ivy, and M.J. Chen Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise Neuropsychopharmacology 29 2004 2189 2199 (Pubitemid 39578909)
41. E.M. Sánchez, A. Bagües, and M.I. Martín Contributions of peripheral and central opioid receptors to antinociception in rat muscle pain models Pharmacol. Biochem. Behav. 96 2010 488 495
42. A. Sarandol, E. Sarandol, S.S. Eker, S. Erdin, E. Vatansever, and S. Kirli Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems Hum. Psychopharmacol. Clin. Exp. 22 2007 67 73 (Pubitemid 46505714)
43. Y. Shirayama, H. Ishida, M. Iwata, G.I. Hazama, R. Kawahara, and R.S. Duman Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects J. Neurochem. 90 2004 1258 1268 (Pubitemid 39167359)
44. H. Tsuboi, A. Tatsumi, K. Yamamoto, F. Kobayashi, K. Shimoi, and N. Kinae Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants J. Affect. Disord. 91 2006 63 70 (Pubitemid 43254640)
45. Y.H. Wang, J.F. Sun, Y.M. Tao, Z.Q. Chi, and J.G. Liu The role of κ-opioid receptor activation in mediating antinociception and addiction Acta Pharmacol. Sin. 31 2010 1065 1070
46. H.L. Yang, S.C. Chen, K.J.S. Kumar, K.N. Yu, D.L. Chao, S.Y. Tsai, Y.C. Hou, and Y.C. Hseu Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from Hesperitin-administered rat serum: na ex vivo approach J. Agric. Food Chem. 60 2012 522 532
47. H. Zhang, Y.G. Shi, J.H. Woods, S.J. Watson, and M.C. Ko Central kappa - opioid receptor-mediated antidepressant-like effects of nor-binaltorphimine: behavioral and BDNF mRNA expression studies Eur. J. Pharmacol. 570 2007 89 96 (Pubitemid 47247688)